The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated survival with extended follow-up on patients with newly diagnosed multiple myeloma treated with lenalidomide, bortezomib, and dexamethasone (RVD) induction therapy and a risk-stratified maintenance approach.
 
Rujul H Parikh
Honoraria - MJH Life Sciences
 
Craig C. Hofmeister
Honoraria - Amgen; Bluebird Bio
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Genzyme; GlaxoSmithKline; Oncopeptides; Sanofi Pasteur
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Oncopeptides (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Patent related to REC-2282 (formerly AR-42, NSC D736012)
 
Dhwani Almaula
No Relationships to Disclose
 
Leonard T. Heffner
Speakers' Bureau - Kite, a Gilead company
Research Funding - ADC Therapeutics (Inst); Astex Pharmaceuticals (Inst); Cellectar (Inst); Genentech (Inst); Kite, a Gilead company (Inst); Loxo (Inst); Pharmacyclics (Inst)
 
Vikas Anand Gupta
No Relationships to Disclose
 
Lawrence Boise
Consulting or Advisory Role - Abbvie; AstraZeneca/Merck
 
Jonathan L. Kaufman
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; Celgene; Genentech; Incyte; TG Therapeutics
Research Funding - Abbvie/Genentech (Inst); Amgen (Inst); BMS (Inst); Celgene (Inst); Fortis (Inst); Janssen (Inst); Merck (Inst); Sutro Biopharma (Inst)
 
Madhav V. Dhodapkar
Consulting or Advisory Role - Janssen Oncology; lava therapeutics; Roche/Genentech
 
Sagar Lonial
Stock and Other Ownership Interests - TG Therapeutics
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Novartis; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Takeda
Other Relationship - TG Therapeutics
 
Ajay K. Nooka
Honoraria - Adaptive Biotechnologies; Amgen; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb/Celgene; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Secura Bio; Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Secura Bio; Takeda
Research Funding - Amgen (Inst); Arch Oncology (Inst); Bristol-Myers Squibb/Celgene (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Nisha Joseph
No Relationships to Disclose